Price T Rowe Associates Inc. MD Increases Position in Genpact Limited $G

Key Points

• Price T Rowe Associates Inc. MD significantly increased its holdings in Genpact Limited by 421.4%, acquiring an additional 620,201 shares, bringing its total to 767,386 shares valued at $38.66 million.
• Genpact reported quarterly earnings of $0.88 EPS, exceeding analysts' expectations, and announced a quarterly dividend of $0.17 per share, yielding 1.5% annually.
• Institutional investors own 96.03% of Genpact's stock, indicating strong interest among large funds and a high confidence level in the company.

Price T Rowe Associates Inc. MD increased its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 421.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 767,386 shares of the business services provider's stock after purchasing an additional 620,201 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 0.44% of Genpact worth $38,662,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in G. Cornerstone Planning Group LLC purchased a new stake in shares of Genpact during the first quarter worth about $27,000. Richardson Financial Services Inc. bought a new position in Genpact during the first quarter valued at approximately $35,000. Global X Japan Co. Ltd. bought a new position in Genpact during the first quarter valued at approximately $57,000. Quarry LP boosted its stake in Genpact by 1,528.6% during the fourth quarter. Quarry LP now owns 1,710 shares of the business services provider's stock valued at $73,000 after buying an additional 1,605 shares during the last quarter. Finally, UMB Bank n.a. boosted its stake in Genpact by 66.2% during the first quarter. UMB Bank n.a. now owns 2,011 shares of the business services provider's stock valued at $101,000 after buying an additional 801 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Trading Up 0.8%

Shares of NYSE G traded up $0.36 during midday trading on Monday, hitting $45.33. The company's stock had a trading volume of 1,706,147 shares, compared to its average volume of 2,032,093. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.32. The business's 50 day moving average is $44.34 and its two-hundred day moving average is $46.49. Genpact Limited has a 12-month low of $37.82 and a 12-month high of $56.76. The firm has a market cap of $7.90 billion, a P/E ratio of 15.06, a price-to-earnings-growth ratio of 1.56 and a beta of 0.92.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 EPS for the quarter, topping the consensus estimate of $0.85 by $0.03. The company had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.Genpact's quarterly revenue was up 6.6% on a year-over-year basis. During the same period last year, the business posted $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, equities research analysts expect that Genpact Limited will post 3.21 EPS for the current year.

Genpact Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.5%. The ex-dividend date is Thursday, September 11th. Genpact's dividend payout ratio (DPR) is presently 22.59%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Deutsche Bank Aktiengesellschaft assumed coverage on Genpact in a research note on Thursday, July 17th. They set a "hold" rating and a $47.00 price target for the company. Robert W. Baird dropped their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. JPMorgan Chase & Co. dropped their price target on Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday, August 20th. Needham & Company LLC increased their price target on Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Finally, Mizuho raised their price objective on Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research note on Tuesday, July 1st. Three investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $52.29.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.